期刊文献+

冠心病危险因素与冠状动脉病变特点的临床分析 被引量:8

Clinical Analysis of Risk Factors for Coronary Heart Disease and Characteristics of Coronary Artery Lesions
下载PDF
导出
摘要 目的探讨冠心病患者冠状动脉病变特点与相关危险因素的关系。方法选择2008-01/2009-07月作者医院收治的因诊断或疑诊为冠心病而行冠状动脉造影的430例住院患者,依据冠状动脉造影显示的冠状动脉病变情况分为冠心病组(282例)和对照组(148例),回顾性分析患者既往是否合并有吸烟、高血压、高脂血症、糖尿病等冠心病危险因素,并与冠状动脉病变的关系进行多元回归分析。结果冠心病组患者的收缩压和脉压差水平、超敏C反应蛋白、血浆纤维蛋白原和糖化血红蛋白水平较对照组均明显升高(P<0.01);性别、年龄、血浆纤维蛋白原、高甘油三脂血症和糖尿病史是冠心病的独立危险因素(P<0.05),且与冠状动脉病变范围和积分密切相关。结论冠心病患者以男性多发,合并有吸烟史、糖尿病史,血清超敏C反应蛋白、血浆纤维蛋白原高水平及高甘油三脂血症的患者是冠心病的高危人群。 Objective To investigate the relationship between the risk factors for coronary heart disease and characteristics of coronary artery lesions.Methods Four hundred and thirty patients diagnosed or suspected as coronary artery heart disease (CHD) in our hospital between January 2008 and July 2009,were divided into coronary heart disease group (CHD group,n=282) and non-coronary heart disease group (control group,n=148) according to the coronary angiography (CAG).The symptoms,signs,laboratory data,CAG and interventional therapy were recorded.The risk factors,including smoking,hypertension,hyperlipemia and diabetes mellitus (DM) of the patients were retrospectively analysed.Multiple regression analysis was used to study the relationship between CHD and these factors.Results The CHD group had higher level of systolic pressure,pulse pressure,hs-CRP,plasma fibrinogen and HbA1c than the control group (P0.01).Sex,age,hypertriglyceridemia,DM and high level of plasma fibrinogen were independent risk factors for CHD.Conclusion Male,smoker,and the patients with DM,hypertriglyceridemia,and high level of hs-CRP or plasma fibrinogen,are high risk population for CHD.
作者 杨娜 丁世芳
出处 《华南国防医学杂志》 CAS 2010年第3期201-204,共4页 Military Medical Journal of South China
关键词 冠心病 危险因素 冠状动脉造影 病变特点 Coronary heart disease Risk factors Coronary artery angiography Lesion characteristics
  • 相关文献

参考文献15

  • 1Kilbourne AM, Brar .IS, Drayer RA, et al. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder and bipolar disorder[J]. Psychosomatics, 2007,48,(5):412.
  • 2Yang X, So WY, Kong A.P, et a l. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus [J]. Am J Cardiol,2008,101 (5) :596-601.
  • 3Wannamethee SG. Serum uric acid and risk of coronary heart disease[J]. Curr Pharm Dis, 2005,11 (32):4125-4132.
  • 4张嘉莹,朱中玉,李牧蔚,陈岩,王现青.青年急性心肌梗死患者脂蛋白(a)水平的变化及其意义[J].临床心血管病杂志,2002,18(10):500-502. 被引量:248
  • 5美国糖尿病学会2007版糖尿病诊疗标准[J].中国糖尿病杂志,2007,15(2):129-130. 被引量:112
  • 6Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographie pattern of restenosis alter rapamycin-eluring st ent implantation[J ]. Circulation, 2003,107 ( 17 ) : 2178-2180.
  • 7Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications[J]. Circulation,2007,116(16) : 1832-1844.
  • 8Renner W,Cichocki L, Forjanics A,et al. G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis[J]. Eur J Clin Invest, 2002,32 (10) : 721-722.
  • 9张廷杰.Framingham心脏研究历史与现状[J].高血压杂志,2003,11(5):404-405. 被引量:34
  • 10Franklin SS, Lsrson MG, Khan SA, et al. Does the relation of bIood pressure to coronary heat disease risk change with aging? The Framingham Heart Study [J]. Circulation, 2001,103 (9) : 1245-1249.

二级参考文献32

  • 1Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 2Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 3Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 4Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
  • 5Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
  • 6Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.
  • 7Greory Y H, Gordon D L. Fibrin D-dimer: A useful marker of thrombogenesis? Clini Sci,1995(89):205-214.
  • 8Grundy SM, Howard B, Smith S, et al. Prevention Conference Ⅵ: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation,2002, 105:2231-2239.
  • 9Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study. Diabetes Care, 2003,26: 868-874.
  • 10Camevale-Schianca GP, Rossi A, Sainaghi PP, et al. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care, 2003,26:1333-1337.

共引文献494

同被引文献74

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部